Tapinarof for psoriasis and atopic dermatitis: 15 years of clinical research

被引：21

作者：

Bissonnette, R. ^{[1
,2
]}

Saint-Cyr Proulx, E. ^{[1
]}

Jack, C. ^{[1
]}

Maari, C. ^{[1
]}

机构：

[1] Innovaderm Res Inc, Montreal, PQ, Canada

[2] Innovaderm Res, 3530 St Laurent Blvd,Suite 300, Montreal, PQ H2X 2V1, Canada

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2023年 / 37卷 / 06期

关键词：

TOPICAL WBI-1001; DOUBLE-BLIND; EFFICACY; SAFETY; CREAM;

D O I：

10.1111/jdv.18925

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Tapinarof is a topical, aryl-hydrocarbon receptor agonist that has recently received FDA-approval for the treatment of psoriasis. This novel therapeutic has also been shown to be effective for atopic dermatitis and is currently in phase 3 for this indication. Beyond good efficacy and fast onset of action in patients with psoriasis, the clinical response to tapinarof is notable for durable remission or near remission, maintained for an average of 130 days beyond treatment discontinuation in patients with psoriasis in phase 3 studies. Tapinarof is usually well tolerated but can induce a follicular inflammatory reaction and dermatitis in some patients. This narrative review covers the historical development of this molecule, safety and efficacy data from clinical trials conducted with various topical formulations, and practical considerations derived from our 15 years of clinical trial experience with the drug.

引用

页码：1168 / 1174

页数：7

共 26 条

[11] Tapinarof Cream 1% for Extensive Plaque Psoriasis: A Maximal Use Trial on Safety, Tolerability, and Pharmacokinetics [J].

Jett, John E. ;

McLaughlin, Michael ;

Lee, Mark S. ;

Parish, Lawrence Charles ;

DuBois, Janet ;

Raoof, Tooraj Joseph ;

Tabolt, Glenn ;

Wilson, Timothy ;

Somerville, Matthew C. ;

DellaMaestra, Wayne ;

Piscitelli, Stephen C. .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (01) :83-91

[12] Phase 3 Trials of Tapinarof Cream for Plaque Psoriasis [J].

Lebwohl, Mark G. ;

Stein Gold, Linda ;

Strober, Bruce ;

Papp, Kim A. ;

Armstrong, April W. ;

Bagel, Jerry ;

Kircik, Leon ;

Ehst, Benjamin ;

Hong, H. Chih-ho ;

Soung, Jennifer ;

Fromowitz, Jeff ;

Guenthner, Scott ;

Piscitelli, Stephen C. ;

Rubenstein, David S. ;

Brown, Philip M. ;

Tallman, Anna M. ;

Bissonnette, Robert .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24) :2219-2229

[13] IDENTIFICATION OF 2 PIGMENTS AND A HYDROXYSTILBENE ANTIBIOTIC FROM PHOTORHABDUS-LUMINESCENS [J].

LI, JX ;

CHEN, GH ;

WU, HM ;

WEBSTER, JM .

APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 1995, 61 (12) :4329-4333

[14] Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role? [J].

Megna, Matteo ;

Caiazzo, Giuseppina ;

Parisi, Melania ;

Ruggiero, Angelo ;

Capasso, Gianmarco ;

Mascolo, Massimo ;

Russo, Daniela ;

Gallo, Lucia ;

Fabbrocini, Gabriella ;

Napolitano, Maddalena ;

Patruno, Cataldo .

CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (05) :918-925

[15]

Mooney N, 2022, J INVEST DERMATOL, V142, pB26

[16] A phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of atopic dermatitis [J].

Peppers, Johnny ;

Paller, Amy S. ;

Maeda-Chubachi, Tomoko ;

Wu, Sterling ;

Robbins, Kevin ;

Gallagher, Kelly ;

Kraus, John E. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (01) :89-+

[17] Quinolinic Acid, a Tryptophan Metabolite of the Skin Microbiota, Negatively Regulates NLRP3 Inflammasome AhR in Psoriasis [J].

Qiao, Pei ;

Zhang, Chen ;

Yu, Jinlei ;

Shao, Shuai ;

Zhang, Jieyu ;

Fang, Hui ;

Chen, Jiaoling ;

Luo, Yixin ;

Zhi, Dalong ;

Li, Qingyang ;

Ma, Jingyi ;

Fu, Meng ;

Dang, Erle ;

Yin, Wen ;

Wang, Gang .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) :2184-+

[18] Phase 2, randomized dose-finding study of tapinarof (GSK2894512 cream) for the treatment of plaque psoriasis [J].

Robbins, Kevin ;

Bissonnette, Robert ;

Maeda-Chubachi, Tomoko ;

Ye, Li ;

Peppers, Johnny ;

Gallagher, Kelly ;

Kraus, John E. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 80 (03) :714-721

[19] Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans [J].

Smith, Susan H. ;

Jayawickreme, Channa ;

Rickard, David J. ;

Nicodeme, Edwige ;

Bui, Thi ;

Simmons, Cathy ;

Coquery, Christine M. ;

Neil, Jessica ;

Pryor, William M. ;

Mayhew, David ;

Rajpal, Deepak K. ;

Creech, Katrina ;

Furst, Sylvia ;

Lee, James ;

Wu, Dalei ;

Rastinejad, Fraydoon ;

Willson, Timothy M. ;

Viviani, Fabrice ;

Morris, David C. ;

Moore, John T. ;

Cote-Sierra, Javier .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) :2110-2119

[20] One-year safety and efficacy of tapinarof cream for the treatment of plaque psoriasis: Results from the PSOARING 3 trial [J].

Strober, Bruce ;

Gold, Linda Stein ;

Bissonnette, Robert ;

Armstrong, April W. ;

Kircik, Leon ;

Tyring, Stephen K. ;

Piscitelli, Stephen C. ;

Brown, Philip M. ;

Rubenstein, David S. ;

Tallman, Anna M. ;

Lebwohl, Mark G. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (04) :800-806

← 1 2 3 →